Skip to main content
. 2020 Jun 11;42(1):539–546. doi: 10.1080/0886022X.2020.1772295

Figure 2.

Figure 2.

Levels of plasma IgA1 and galactose-deficient IgA1 in participants. (A) The plasma IgA1 and Gd-IgA1 levels in patients with IgAN and healthy controls. (B) The Plasma IgA1 and Gd-IgA1 levels in IgAN patients with or without H. pylori infection. (C) The Plasma IgA1 and Gd-IgA1 levels in healthy controls with or without H. pylori infection.